Submit your LBCT

Highlight game changers in nephrology by showcasing the results of Late Breaking Clinical Trials of exceptional importance that have not been presented elsewhere, while complying with the following conditions:

Prospective randomized clinical trials with at least 100 randomized patients.
Prospective observational studies with at least 500 patients at follow-up.
A prospective, randomized intervention in the pathology of rare renal diseases, with no limit on the number of patients enrolled.
 
The best Abstracts will be selected for presentation at the LBCT Symposium, and the remaining Abstracts that comply with the rules will be accepted as Focussed Oral or e-poster. 

Starting from 2026, there will be a main LBCT session with no other session in parallel, offering a huge opportunity to present your results in a unique session.

Deadline: March 26, 2025
­
SUBMIT NOW